[Cytokine therapy of metastatic renal cell carcinoma]

¹Urologische Klinik, Universitätsklinkum, GHS, Essen.

|May 1, 1995

Abstract:

Cytokine therapy of metastatic renal cell carcinoma reveals a remission rate of about 25% regarding to the different patients selection criteria, i.e. age, performance status, site of metastasis, tumour load. Remission is not correlated to patient's survival. Adjuvant or neoadjuvant immunotherapy is not a treatment option. Nephrectomy has no influence on distant metastases and should be limited to symptomatic primary tumours. In conclusion, cytokine therapy is not a standard treatment. Its value has to be evaluated in randomized trials.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers].

Der Urologe. Ausg. A·2020

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

World journal of urology·2020

[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].

Der Urologe. Ausg. A·2019

Related Experiment Videos

[Cytokine therapy of metastatic renal cell carcinoma]

Related Concept Videos

[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers].

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].

[When is surgical treatment indicated in metastatic urothelial carcinoma and what is the scientific rationale?]

[Enuresis and pediatric urinary incontinence : Diagnostics and therapy].

[Social support in gender reassignment surgery].

[G-CSF for prophylaxis of neutropenia and febrile neutropenia, anemia in cancer : Guidelines on supportive treatment part 1].

[Multiparametric MRI of the prostate].

[Follow-up in superficial and metastatic bladder cancer].

[Follow-up after urolithiasis management].

[Aftercare and adjuvant therapy for advanced renal cell carcinoma].

Related Experiment Videos

[Cytokine therapy of metastatic renal cell carcinoma]

Abstract:

Related Concept Videos

Related Articles